Robuta

https://www.biospace.com/puma-biotechnology-presents-interim-results-from-the-biliary-tract-cancers-cohort-of-the-phase-ii-summit-basket-trial-of-neratinib-at-asco-gi
Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced interim results from the biliary tract cancers cohort of the ongoing SUMMIT...
biliary tract cancerspuma biotechnologyinterim resultspresents
https://pubmed.ncbi.nlm.nih.gov/23057767/
These findings provide additional support for the role of inflammation in biliary stones and biliary tract cancer risk and need further validation.
biliary tract cancersinflammatorygenevariantsrisk
https://www.nice.org.uk/guidance/conditions-and-diseases/cancer/biliary-tract-cancers
All NICE products on biliary tract cancers. Includes any guidance and advice.
biliary tract cancerstopicnice